About Inovotion
Inovotion is a Healthcare company based in La Tronche (France) founded in 2014. Provider of in vivo oncology efficacy and toxicity assays for drug discovery and development. Its chief executive, as recorded, is Jean Viallet. Inovotion offers products and services including In Vivo Oncology Assays, CAM Technology, and Toxicity Assays. Its focus areas include Life Sciences, Life Sciences Platforms and Tools, Research Assays and Cell Based Assays. Its legal entity is INOVOTION SAS.
Company details
Inovotion was founded in 2014 in La Tronche, France, within the biotechnology sector focused on oncology. In vivo assays for efficacy and toxicity in drug discovery and development are offered by the company. Highly sensitive and reproducible assays for immuno-oncology programs are provided, along with monitoring of human tumor cell growth and metastatic dissemination. Operations support pharmaceutical research through these specialized services.
- Headquarters La Tronche, France
- SectorsHealthcare
- Email••••••••
- Phone•••• ••••
- Website inovotion.com
- Social LinkedIn X
- Legal Name Inovotion Sas
- Latest Funding Round$57.05K (USD), Grant
Jun 2017
- InvestorsEuropean Union
& 1 more
Products & Services of Inovotion
Inovotion offers a comprehensive portfolio of products and services, including In Vivo Oncology Assays, CAM Technology, and Toxicity Assays.
Assays for evaluating drug efficacy and toxicity in oncology research.
Platform for studying tumor growth and metastasis in vivo models.
Services for assessing drug safety and target validation in medicine.
Funding Insights of Inovotion
- Total Rounds 2
- Last Round Grant — $57,046
- First Round $52,500
(Jan 2017)
- Investors Count 2
All 2 funding rounds of Inovotion with amounts and investors; the two latest post-money valuations are shown, the rest are part of the premium plan.
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Jun 2017 | $57,046 | Grant | – | – | |
| Jan 2017 | $52,500 | Grant | – | – |
2 investors in total: 2 institutional.
Investors in Inovotion
Inovotion has secured backing from 2 investors, including venture fund and institutional investors. Prominent investors backing the company include European Union and EIC Fund.
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
Government agency and accelerator focusing on innovative startups and SMEs | eicfund.eu | Brussels, Belgium | ||
Government entites focused on freedom, democracy, equality and the rule of law, promoting peace and stability | 1958 | europa.eu | Brussels, Belgium |
Investor details for Inovotion
The complete investor list, round-by-round participation and investor portfolios require an active premium plan.
- Complete investor list
- Round participation
- Investor portfolios
- Co-investor network
Verified entity values are shown only after access is granted.
People of Inovotion
1 people are tracked at Inovotion (1 in leadership).
| Name | Role | Group |
|---|---|---|
Jean Viallet | CEO | Leadership |
Complete people profiles for Inovotion
Full employee and board profiles, team structure, tenure and professional contact details require an active premium plan.
- Full employee list
- Team structure
- Board tenure
- Professional contacts
Verified entity values are shown only after access is granted.
Timeline of Inovotion
3 dated milestones of Inovotion across 3 years, from founding to its latest funding, stage changes and deals.
- Founded Inovotion is founded.
- Funding First funding round of $52K.
- Funding Latest funding round, Grant, of $57K.
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Frequently Asked Questions about Inovotion
Inovotion was founded in 2014 and raised its 1st funding round 3 years after it was founded.
Inovotion is headquartered in La Tronche, France. It is registered at La Tronche, Auvergne-rhone-alpes, France.
Jean Viallet is the CEO of Inovotion, as recorded in our data.
Inovotion was founded in 2014 in La Tronche, France, within the biotechnology sector focused on oncology. In vivo assays for efficacy and toxicity in drug discovery and development are offered by the company. Highly sensitive and reproducible assays for immuno-oncology programs are provided, along with monitoring of human tumor cell growth and metastatic dissemination. Operations support pharmaceutical research through these specialized services.
Inovotion offers In Vivo Oncology Assays, CAM Technology, and Toxicity Assays.
Inovotion has 2 investors. Key investors include European Union, and EIC Fund.
Inovotion operates through Inovotion Sas.